Literature DB >> 20676146

Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?

Samuel M Behar1, Maziar Divangahi, Heinz G Remold.   

Abstract

Virulent Mycobacterium tuberculosis inhibits apoptosis and triggers necrosis of host macrophages to evade innate immunity and delay the initiation of adaptive immunity. By contrast, attenuated M. tuberculosis induces macrophage apoptosis, an innate defence mechanism that reduces bacterial viability. In this Opinion article, we describe how virulent M. tuberculosis blocks production of the eicosanoid lipid mediator prostaglandin E(2) (PGE(2)). PGE(2) production by infected macrophages prevents mitochondrial damage and initiates plasma membrane repair, two processes that are crucial for preventing necrosis and inducing apoptosis. Thus, M. tuberculosis-mediated modulation of eicosanoid production determines the death modality of the infected macrophage, which in turn has a substantial impact on the outcome of infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676146      PMCID: PMC3221965          DOI: 10.1038/nrmicro2387

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  62 in total

1.  Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

Authors:  J Keane; H G Remold; H Kornfeld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes?

Authors:  Tamás Laskay; Ger van Zandbergen; Werner Solbach
Journal:  Trends Microbiol       Date:  2003-05       Impact factor: 17.079

3.  Cytosolic phospholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra.

Authors:  L Duan; H Gan; J Arm; H G Remold
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

4.  Lipid mediator class switching during acute inflammation: signals in resolution.

Authors:  B D Levy; C B Clish; B Schmidt; K Gronert; C N Serhan
Journal:  Nat Immunol       Date:  2001-07       Impact factor: 25.606

Review 5.  Cyclooxygenases and prostaglandins: shaping up the immune response.

Authors:  Bianca Rocca; Garret A FitzGerald
Journal:  Int Immunopharmacol       Date:  2002-04       Impact factor: 4.932

Review 6.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.

Authors:  Charles N Serhan; Nan Chiang; Thomas E Van Dyke
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 7.  EP2 and EP4 prostanoid receptor signaling.

Authors:  John W Regan
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

8.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  Long-term potentiation of exocytosis and cell membrane repair in fibroblasts.

Authors:  Tatsuru Togo; Janet M Alderton; Richard A Steinhardt
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

10.  Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.

Authors:  M Murakami; H Naraba; T Tanioka; N Semmyo; Y Nakatani; F Kojima; T Ikeda; M Fueki; A Ueno; S Oh; I Kudo
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

View more
  184 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival.

Authors:  Laura J Macdonald; Joseph G Graham; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-10-09       Impact factor: 3.715

Review 3.  Apoptosis inhibition by intracellular bacteria and its consequence on host immunity.

Authors:  Samuel M Behar; Volker Briken
Journal:  Curr Opin Immunol       Date:  2019-06-19       Impact factor: 7.486

Review 4.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 5.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

6.  Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia.

Authors:  Anju Singh; Tabassum Rahman; Rose Bartiss; Alireza Arabshahi; Jeevan Prasain; Stephen Barnes; Florin Marcel Musteata; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

7.  Mycobacterium tuberculosis impairs dendritic cell functions through the serine hydrolase Hip1.

Authors:  Ranjna Madan-Lala; Jonathan Kevin Sia; Rebecca King; Toidi Adekambi; Leticia Monin; Shabaana A Khader; Bali Pulendran; Jyothi Rengarajan
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

Review 8.  Macrophages clean up: efferocytosis and microbial control.

Authors:  Constance J Martin; Kristen N Peters; Samuel M Behar
Journal:  Curr Opin Microbiol       Date:  2013-12-05       Impact factor: 7.934

Review 9.  Disruption of immune regulation by microbial pathogens and resulting chronic inflammation.

Authors:  Kenneth Barth; Daniel G Remick; Caroline A Genco
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

10.  Intramacrophage Infection Reinforces the Virulence of Edwardsiella tarda.

Authors:  Lingzhi Zhang; Chunshan Ni; Wenting Xu; Tongcheng Dai; Dahai Yang; Qiyao Wang; Yuanxing Zhang; Qin Liu
Journal:  J Bacteriol       Date:  2016-04-28       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.